Full Text
EE147 A Cost-Effectiveness Analysis of Pemigatinib Versus Gemcitabine/Cisplatin Therapy in Patients with Cholangiocarcinoma

Abstract

Authors

L. Anderson T. Bruno L. Villa Zapata

Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×